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Abstract
Psychopathology  represents  a  leading  cause  of  disability  worldwide.  Effective
interventions need to target risk factors that are causally related to psychopathology. In order
to  distinguish  between  causal  and  spurious  risk  factors,  it  is  critical  to  account  for
environmental  and  genetic  confounding.  Mendelian  randomisation  studies  use  genetic
variants  that  are  independent  from  environmental  and  genetic  confounders  in  order  to
strengthen causal  inference.  We conducted a systematic  review of studies (N = 19) using
Mendelian  randomisation  to  examine  the  causal  role  of  putative  risk  factors  for
psychopathology-related  outcomes  including  depression,  anxiety,  psychological  distress,
schizophrenia,  substance  abuse/antisocial  behaviour,  and  smoking  initiation.  The  most
commonly  examined  risk  factors  in  the  reviewed  Mendelian  randomisation  studies  were
smoking,  alcohol  use  and  body  mass  index.  In  most  cases,  risk  factors  were  strongly
associated with psychopathology-related outcomes in conventional analyses but Mendelian
randomisation  indicated  that  these  associations  were  unlikely  to  be  causal.  However,
Mendelian  randomisation  analyses  showed  that  both  smoking  and  homocysteine  plasma
levels  may  be  causally  linked  with  schizophrenia.  We discuss  possible  reasons  for  these
diverging results  between conventional and Mendelian randomisation analyses and outline
future directions for progressing research in ways that maximise the potential for identifying
targets for intervention.
Keywords: psychopathology, risk factors, Mendelian randomization,  causality, smoking,
alcohol, body mass index, depression, anxiety, schizophrenia
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Introduction
   Psychopathology is a major public health concern and the leading contributor for years
lived with disability world-wide (Whiteford et al., 2013). Identifying modifiable 
environmental exposures that are causally related to psychopathology is crucial for designing 
effective evidence-based social policies and interventions. To date, however, establishing 
whether a correlation between an environmental exposure (e.g. smoking) and a 
psychopathology-related outcome (e.g. depression) reflects a truly causal relationship or a 
spurious association remains a major challenge. To address this issue, Mendelian 
Randomisation (MR) has been developed as a method using genetic information for 
strengthening causal inference about environmental risk factors in observational research 
(Davey Smith, 2010). The present systematic review examines MR studies that included 
psychopathology-related outcomes. In the introduction, we briefly elaborate on causal 
inference in psychopathology before explaining the principles, strengths and limitations of 
MR. 
Causal inference in psychopathology
A fundamental objective of epidemiological approaches to psychopathology is to identify 
modifiable environmental exposures that can be targeted in effective interventions. To this 
end, establishing causality is crucial: an intervention is extremely unlikely to succeed if the 
targeted environmental exposure is not causally related to the outcome, simply because if 
exposure A does not cause outcome B, then modifying A will not change B. 
Relying on observational studies to identify such potential targets for intervention is 
problematic. Observational studies suffer from limitations that prevent causal inference such 
as environmental and genetic confounding (Richmond, Al-Amin, Davey Smith, & Relton, 
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2014). For instance, smoking and depression are strongly associated in the general population:
heavy smokers are more likely than moderate or non-smokers to suffer from depression 
(Bjørngaard et al., 2013; Lewis et al., 2011). However, many confounding factors could drive 
this association. For instance, a third variable, such as socioeconomic adversity, which 
associates with both higher rates of depression (Melchior et al., 2013) and smoking (Pingault 
et al., 2013) could account for the association. An association between smoking and 
depression could also arise from partially overlapping genetic risk factors (Kendler et al., 
1993). If environmental and/or genetic confounding totally account for the observed 
association, the relationship between smoking and depression cannot be described as causal. 
Considerable effort has been directed at strengthening causal inferences in observational 
studies (Imai, King, & Stuart, 2008; Jaffee, Strait, & Odgers, 2012; Rutter, 2007; Rutter, 
Pickles, Murray, & Eaves, 2001), for instance by using statistical innovation such as matching
techniques to balance confounders between exposed or non-exposed groups (Ho, Imai, King, 
& Stuart, 2007; Stuart, 2010; Stuart & Green, 2008), or using cross-cohort comparison to 
better account for confounding (Lewis, Relton, Zammit, & Davey Smith, 2013). In addition to
these techniques, genetically informative designs have addressed the issue of genetic 
confounding. Family-based designs such as the discordant monozygotic twin or the in vitro 
fertilization designs account for genetic confounding using known genetic similarities 
between family members. Reviewing the many family-based designs is beyond the scope of 
this article and can be found elsewhere (D’Onofrio, Class, Lahey, & Larsson, 2014; Jaffee et 
al., 2012; Lewis et al., 2013). MR is a recently developed method also using genetic 
epidemiology to strengthen causal inference (Davey Smith & Ebrahim, 2005). However, 
unlike family-based designs, MR does not require family-based samples and uses direct 
genotyping instead of relying on genetic similarities between family members. 
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MR and other techniques for strengthening causal inference in observational research are 
essential for several reasons. First, experimental manipulations of presumed environmental 
risk factors to test whether they play a causal role are not always possible for ethical reasons 
(e.g. neglect or maternal smoking). Second, even when feasible, experimental manipulations 
such as randomised controlled trials suffer from their own limitations (e.g. highly selected 
volunteers, which may not be representative of the target population, see Imai et al., 2008; 
Jaffee & Price, 2012). In such cases, MR and other techniques offer unique strengths to test 
putative causal relations. Finally, many costly randomised controlled trials have failed to 
confirm associations reported in observational studies (Davey Smith & Hemani, 2014). 
Therefore, implementing techniques to strengthen causal inference in observational studies is 
an important step for guiding the choice of appropriate intervention targets before investing in
a randomised controlled trial. 
Modifiable environmental exposures and genetic instruments
The aim of MR is to test whether a potentially modifiable environmental exposure is 
causally related to an outcome of interest. The “potentially modifiable environmental 
exposure” can either be a modifiable behaviour such as smoking or an intermediate phenotype
such as cholesterol levels (Sheehan, Didelez, Burton, & Tobin, 2008). MR first involves the 
identification of a genetic variant that influences the exposure variable. The genetic variant 
must either alter the level of the exposure itself – e.g. increase in smoking – or mirror its 
biological effect – e.g. modify cholesterol levels (Bennett, 2010; Davey Smith et al., 2005; 
Gage, Davey Smith, Zammit, Hickman, & Munafò, 2013). Importantly, the focus of MR is 
not the genetic variant itself but rather the potential causal relationship between the 
environmental exposure and the outcome. As such, MR does not aim to identify genetic 
factors in order to target individuals on the basis of their genotype. Rather, it uses genetic 
              Running head: MENDELIAN RANDOMISATION and PSYCHOPATHOLOGY 8
variants that are known to affect exposure to environmental risk, in order to test whether 
specific environmental exposures are causally related to the outcomes of interest (Sheehan et 
al., 2008). These genetic variants are called ‘genetic instruments’ because they are used in an 
instrumental fashion – as a mean to an end – to examine causality. 
Principles of Mendelian randomisation
MR is based on the following logical proposition: if an exposure A causes an outcome B, 
then any variable that influences A will also influence B (Davey Smith & Hemani, 2014). The
genetic instrument is chosen because it is known to influence A. If there is a causal 
relationship between A and B, then the genetic instrument that influences A should also 
influence B. If we observe that the genetic instrument indeed influences B, we can conclude 
that there is a causal relationship between A and B, provided all assumptions are met (see 
Figure 1). A critical assumption is that all the effect of the genetic instrument on the outcome 
B must happen through the exposure A (i.e. similar to full mediation). Provided this 
assumption is met, if the path from the genetic instrument to A is significant, and if the path 
from the genetic instrument to B is also significant, then we have all the information needed 
to estimate the relationship of interest, i.e. the path between exposure A and outcome B. 
Once the causal influence between A and B is established, it also follows from the same 
initial proposition that any other factor influencing A should influence B (additional 
considerations on this topic can be found in Burgess, Butterworth, Malarstig, & Thompson, 
2012). In particular, any intervention that would be successful in modifying the exposure A, 
should also be successful at modifying the outcome B. For instance, if MR provides evidence 
that a modifiable behaviour such as smoking is causally related to an outcome such as 
depression, then an efficient smoking cessation intervention should also have a positive 
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impact on depression. Similarly, if MR provides evidence that an intermediate phenotype such
as high BMI causes cardiovascular diseases, then a diet that successfully reduces BMI should 
also reduce cardiovascular diseases. Here, the notion of “intermediate phenotype” refers to 
any phenotype that lies on the causal pathway leading to the outcome of interest. Intermediate
phenotypes can therefore be influenced by genes (e.g. by a genetic instrument) or by the 
environment (e.g. by an intervention such as a diet). 
MR is an example of “instrumental variable”, an approach developed in economics to 
better account for confounding in observational research (Gage et al., 2013). 
An instrumental variable must meet the following assumptions represented in Figure 1 to 
enable adequate causal inference (Gage et al., 2013; Sheehan et al., 2008):
I) It must be associated with the exposure; 
II) It cannot be associated with the outcome of interest, except via its effect on the 
exposure. In other words, all the effect of the instrumental variable should be mediated
by the exposure (i.e. no direct effect remains and no effect is mediated via another 
exposure);
III) It must be independent of all variables (measured or not) that confound the 
relationship between exposure and outcome; and
IV) It must not introduce new confounders to the relationship.
As can be seen, the instrumental variable approach behind MR involves stringent 
assumptions. For instance, most measures of environmental risk are unlikely to fulfil these 
assumptions as they tend to cluster together and, consequently, cannot be independent of 
measured or unmeasured confounders (Davey Smith et al., 2007). Genetic variants retain 
critical advantages as instrumental variables. Based on Mendel’s first law of segregation, 
alleles segregate at conception independently of the environment. Following Mendel’s second
law of independent assortment, genetic variants are inherited independently of each other. 
Therefore, a genetic variant will generally not be associated with environmental or genetic 
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confounding factors that can bias observational studies (Brion, Benyamin, Visscher, & Davey 
Smith, 2014; Davey Smith, 2010).
We can use the association between smoking heaviness and depression as a brief concrete 
example of MR analysis. A genetic variant, the single nucleotide polymorphism (SNP) 
rs1051730 located in the nicotine acetylcholine receptor gene cluster (CHRNA5-A3-B4), has 
been used as a genetic instrument to examine this association. This SNP has been repeatedly 
associated with smoking, the T allele being associated with increased smoking. The first 
condition for MR analysis is therefore satisfied as the genetic instrument must be robustly 
associated with the exposure (Bjørngaard et al., 2013; Lewis et al., 2011; Taylor, Fluharty, et 
al., 2014). The final step is to test whether this genetic instrument is significantly associated 
with the outcome. Because the genetic instrument is supposed to have an effect on the 
outcome only via the exposure (see assumption II), this means that, in the absence of the 
exposure (i.e. among non-smokers), the genetic instrument should have no effect on the 
outcome. We therefore need to test whether smokers with the T allele are more depressed, 
while non-smokers with the T allele show no differences in depression status. If this is the 
case, then we can derive from the instrumental variable approach that increased smoking 
causally increases the risk of depression. Conversely, if no significant association is found 
between the genetic instrument and the outcome, this is interpreted as evidence against a 
causal association. The implementation of MR analysis is straightforward as it relies on a 
simple test of the association between the genetic instrument and the outcome. More 
sophisticated statistical techniques are also available, for instance to calculate the  size of the 
causal effect or to deal with several genetic instruments (Davey Smith & Hemani, 2014).
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------------------------------------------------------------------------
Box1: Analogy between MR and Randomised Controlled Trials (RCT)
The analogy between randomised controlled trials and MR can help to illustrate the 
principles of the design (see Figure 2). We take the basic example of a trial aiming to assess 
the role of a smoking cessation intervention (the treatment) on depression (the outcome). The 
treatment is allocated at random creating two groups, the treatment group and the control 
group. When comparing outcomes between treatment and control groups, all measured and 
unmeasured confounders are accounted for by the randomisation – i.e. there should be no 
significant difference in means of potential confounders between the two groups. As a result, 
the only possible differences between the two groups are due to the causal effect of the 
intervention on some modifiable behaviour, here fewer cigarettes per day for instance. In an 
intent-to-treat analysis, which compares the treatment vs. the control groups independently of 
compliance to the treatment, the randomly allocated smoking cessation intervention is used as
a predictor of depression. Any significant difference in outcome between the two groups is 
interpreted as reflecting the causal effect of the intervention on the outcome. By corollary, the 
effect is interpreted as evidence that fewer cigarettes per day lead to less depression, i.e. that 
the modifiable behaviour and the outcome are causally related. It is important to note, 
however, that this last causal inference relies on several assumptions, including that the effect 
of the treatment is mediated only by the exposure. Instead, it is possible that this effect on 
derpression has nothing to do with less smoking but is due to, for example, an improved 
social network following the intervention. This is analogous to the second assumption for 
instrumental variables: the effects of both the intervention (random allocation) and the genetic
instrument (‘genetic allocation’) should be fully mediated by the exposure. 
Finally, the random treatment allocation in RCTs and the “genetic allocation” in MR both 
affect the exposure (e.g. smoking), and are used to infer the causal effect of the exposure on 
the outcome (e.g. smoking on depression). This is because the genetic allocation also creates a
situation where carriers versus non-carriers of a given allele only differ on the level of the 
exposure of interest (e.g. smoking), as environmental and genetic confounders are balanced. 
Further comments on the analogy between randomised controlled trials and MR can be found 
elsewhere (Bennett, 2010; Davey Smith & Hemani, 2014; Nitsch et al., 2006).  
------------------------------------------------------------------------
Limitations of Mendelian randomisation
Here, we briefly review the main limitations of MR (see Davey Smith & Hemani, 2014 for 
a more extensive review). First, the application of the method is currently limited because: (a) 
the number of exposure variables for which an adequate genetic instrument is available is 
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small, and (b) large samples are needed to achieve sufficient power to detect causal effects 
(Brion, Shakhbazov, & Visscher, 2013). Identifying new genetic instruments and increasing 
sample sizes will partly mitigate this issue. Second, the assumptions of MR may be violated, 
which can lead to incorrect causal inference. Main sources of concern are population 
stratification, linkage disequilibrium and pleiotropy. Population stratification is essentially a 
problem of the genetic instrument being associated with an ethnicity confounder. When 
subgroups in the population differ both in disease rates and allele frequencies for the genetic 
instrument, population stratification becomes a common cause of both and generates a 
spurious association between the two (Brion et al., 2014; Davey Smith & Hemani, 2014; 
Gage et al., 2013). Linkage disequilibrium describes instances where genetic variants are 
correlated with each other more than would be expected by chance (i.e. an exception to the 
Mendel’s law of independent assortment). If the genetic instrument is in linkage 
disequilibrium with another genetic variant that causes the outcome via another exposure 
variable, then the causal inference in an MR study may be invalid (Gage et al., 2013; Sheehan
et al., 2008). The use of several independent genetic variants to examine the effect of a single 
exposure can mitigate this issue. Pleiotropy refers to cases where the genetic instrument has 
an effect on the outcome via multiple intermediate phenotypes, i.e. the second assumption of 
instrumental variables is violated (although not all types of pleiotropic effects are problematic,
see Davey Smith & Hemani, 2014). Several sensitivity analyses can be used to test whether 
pleiotropy may be an issue. For example, when using MR to study the effects of smoking 
severity on depression, one can test to confirm that the genetic instrument is associated with 
the outcome only in smokers and not in non-smokers (Gage et al., 2013). Further comments 
on pleiotropy can be found in the discussion.
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We now review studies that have applied Mendelian randomisation analysis to assess the 
effects of exposures on psychopathology-related outcomes. We expect to provide insights 
regarding the usefulness and limits of MR in psychopathology research as well as to delineate
potential research avenues.
Method
Inclusion criteria
The present systematic review aimed to include all studies that applied MR to one or 
several psychopathology-related outcomes. Given that the MR method was developed 
relatively recently, all types of psychopathology-related outcomes were considered (e.g. 
schizophrenia, depression, psychological distress, addictions). In addition, no restriction was 
applied regarding the operationalisation of psychopathology constructs (i.e. diagnosis or 
symptoms) and the type of sample (e.g. clinical or population sample). 
  
Search strategy
PubMed and PsycINFO were searched for MR studies. In PubMed, the pre-existing key 
word "Mendelian Randomisation Analysis"[Mesh] was used as well as the free search – 
"Mendelian randomization" or "Mendelian randomisation" – to account for American versus 
British spelling. In PsycINFO, no pre-existing key word was found so the same free search 
was conducted. Only studies published in English were considered.  The last search was 
performed on the 31st of July 2015. 
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Study selection
The search in the two databases yielded 838 records, with 591 remaining after filtering for 
duplicates. Titles and abstracts were then screened and a vast majority of these 591 reports 
were excluded as they used MR but did not include psychopathology-related outcomes. 
Empirical studies not using MR and non-empirical reports (e.g. reviews or comments) were 
also excluded. If in doubt, the records were retained for the next step. A total of 21 records 
were selected at this stage. The 21 full-text articles were then assessed for eligibility and 3 
were removed (one editorial comment, and two studies that did not directly assess genetic 
variants). In addition, 1 additional relevant study (Almeida et al., 2009) was found in the 
references of an included article. The systematic review therefore included 19 studies.  
Results
Table 1 presents a synopsis of studies included in the systematic review. Among the 19 
studies included, 14 examined one or a combination of outcomes related to anxiety, 
depression and psychological distress. We first examine these studies before turning to the 
others, which were on schizophrenia, substance use/antisocial personality disorder and 
smoking initiation. 
Studies on anxiety, depression and psychological distress 
The exposure variables examined in these 14 studies were smoking (n = 4), alcohol intake 
(n = 2), body mass index (n = 5), fatty acids (n = 1) and C-reactive protein (n = 2). 
 Smoking. The single nucleotide polymorphism (SNP) located in the nicotine acetylcholine 
receptor gene cluster (CHRNA5-A3-B4) was used to study effects of smoking in four MR 
studies (Bjørngaard et al., 2013; Lewis et al., 2011; Taylor, Fluharty, et al., 2014; Wium-
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Andersen, Ørsted, & Nordestgaard, 2015). It is worth noting that not all these studies are 
independent as two (Bjørngaard et al., 2013; Lewis et al., 2011) were included in the 
consortium analysis (Taylor, Fluharty, et al., 2014). As expected, all four studies using this 
SNP found that that the risk allele was associated with increased smoking heaviness as 
measured by the number of cigarettes smoked. All four studies also reported that increased 
smoking was substantially associated with higher levels of anxiety, depression or 
psychological distress in conventional analyses adjusting for covariates. However, MR 
analyses showed that the risk allele did not predict higher levels of depression, anxiety or 
psychological distress in smokers. As laid out in the introduction, the absence of a significant 
relationship between the genetic instrument (that predicts environmental exposure) and the 
outcome is interpreted as evidence against the existence of a causal association. Therefore, the
findings of these studies do not support the notion that smoking heaviness causes any of these 
outcomes. In one study (Lewis et al., 2011), among women who smoked pre-pregnancy, those
with the risk allele smoked more during pregnancy but were less likely to report high levels of
depressed mood at 18 weeks of pregnancy. These results are consistent with a self-medication 
hypothesis, whereby smoking is used to alleviate symptoms of depression. One of these four 
studies (Wium-Andersen, Ørsted, & Nordestgaard, 2015) included several other 
psychopathology-related outcomes (i.e. antidepressant medication use, schizophrenia and 
antipsychotic medication use) and compared the results with those for chronic obstructive 
pulmonary disease. Results for antidepressant medication use were similar to those found for 
depression, i.e. no evidence of a causal association. As expected, MR analysis indicated a 
causal role of smoking on chronic obstructive pulmonary disease. Results for schizophrenia 
and antipsychotic medication are discussed below together with other studies on 
schizophrenia.
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Alcohol. One study examined the relationship between alcohol use and depression in men 
aged over 65 years (Almeida, Hankey, Yeap, Golledge, & Flicker, 2014). A variant of the 
alcohol dehydrogenase 1B (ADH1B) gene, which reduces the ability to oxidize ethanol, was 
used as a genetic instrument. Faster metabolizers tend to consume more alcohol. The average 
number of drinks per day was related to depression in standard regression analyses adjusting 
for covariates. However, in the MR analyses, the genetic instrument was not associated with 
depression and therefore provided evidence against causality. The other study (Wium-
Andersen, Ørsted, Tolstrup, & Nordestgaard, 2015) examined alcohol use in relation to 
depression and psychological distress. In analyses with adjustment for covariates, alcohol use 
was not related with prescription of antidepressants or hospitalization/death with depression 
but was related with self-reported antidepressant use and items assessing psychological 
distress. However, the genetic variants were not related to any outcome, thus providing 
evidence against the notion that alcohol use is causally related to any of these outcomes. 
Interestingly, this study also included the outcome hospitalization/death with alcoholism. 
Contrary to what was observed for depression, the MR analysis supported a causal 
relationship between alcohol use and hospitalization/death with alcoholism.    
 Body Mass Index (BMI). Five studies used BMI as an intermediate phenotype that can be 
modified by an environmental intervention. The aim was to assess whether BMI was causally 
related with various measures of anxiety, depression and psychological distress. Four studies 
used a variant in the FaT mass and Obesity-associated (FTO) gene (Hung et al., 2014; 
Kivimäki, Jokela, Hamer, et al., 2011; Lawlor et al., 2011; Walter et al., 2015) and 3 used a 
polygenic risk score (Hung et al., 2014; Jokela et al., 2012; Walter et al., 2015). All studies 
found that, in conventional analyses adjusting for covariates, higher BMI was associated with 
higher levels of their respective measures of anxiety, depression and psychological distress. 
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However, MR findings were somewhat contradictory between the five studies. No evidence 
for a causal effect of  BMI was detected in one study of major depression (Hung et al., 2014) 
and another using a standardized depression scale (Walter et al., 2015). A third study reported 
evidence that higher BMI was causally related to more self-reported depression and anxiety 
symptoms only in men (Kivimäki, Jokela, Hamer, et al., 2011). A fourth study using a 
polygenic risk score as a genetic instrument provided evidence that higher BMI increased the 
risk of depressive symptoms, in particular in adolescents (Jokela et al., 2012). Finally, MR 
analyses in the largest study suggested that the association was in the opposite direction, with 
higher BMI being related to less psychological distress (Lawlor et al., 2011). This latter 
finding supports the “fat-jolly” versus the “fat-sad” hypothesis (Kivimäki, Jokela, & Batty, 
2011). These contradictory findings in MR analyses may be explained in various ways. First, 
both the constructs and the assessment methods varied widely, from a clinical assessment of 
depression to a 4-item measure of psychological distress. Second, the MR assumption that the
effect of the genetic instrument should be entirely mediated by the intermediate phenotype – 
here BMI – was not always met (Kivimäki, Jokela, Hamer, et al., 2011; Walter et al., 2015), 
casting doubt on the validity of the analyses. Overall, the MR analyses showed that results 
from conventional analyses adjusting for covariates, which favour the “fat-sad” hypothesis, 
should be considered carefully until additional evidence is gathered. 
Omega-3. One study (Sallis, Steer, Paternoster, Davey Smith, & Evans, 2014) examined  
the association between two omega-3 Fatty Acids - docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA) – and depression-related outcomes, including perinatal-onset 
depression, antenatal depression and postnatal depression. Omega-3 fatty acids might affect 
brain function and behaviour and observational studies report an inverse relationship between 
fish consumption (a major source of omega-3) and depression. To test the likelihood of a 
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protective causal effect of fatty acids on depression, the authors used polygenic risk scores 
predicting DHA and EPA. However, only the polygenic score predicting DHA was significant 
in the study sample so that no MR analysis using EPA was conducted. Finally, the evidence 
for an association between fatty acids and depression was weak in conventional analyses 
adjusting for covariates and null in MR analysis. 
C-reactive protein. A study of men aged over 65 years examined whether the inflammatory
biomarker C-reactive protein, which rises after tissue injury or bacterial infection, was 
causally linked to depression, using 2 SNPs in the C-reactive protein (CRP) gene (Almeida et 
al., 2009). A higher level of C-reactive protein was linked to higher depression in bivariate 
analyses but this was no longer the case in analyses adjusting for covariates. MR analyses also
suggested that this relationship was unlikely to be causal. One allele associated with lower C-
reactive protein levels was actually associated with higher depression, suggesting a causal 
association in the opposite direction. However, a large population-based study did not confirm
this finding when examining the association between C-reactive protein, depression, 
psychological distress and major somatic diseases (Wium-Andersen, Ørsted, & Nordestgaard, 
2014a). In this study, conventional analyses showed significant relations between C-reactive 
protein and all outcomes including hospitalization with depression, anti-depressant use, 
psychological distress and several somatic diseases (e.g. cancer, ischemic heart disease, all-
cause mortality). However, none of these associations were significant in MR analyses and, in
some cases, the MR estimates were significantly lower than the conventional estimates, 
suggesting that conventional analyses are biased by confounding variables even after 
adjustment for covariates.
Studies of schizophrenia.
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 C-reactive protein. The relationship between C-reactive protein and schizophrenia was 
investigated in the same sample as above as it has been suggested that inflammation could be 
involved in the pathogenesis of schizophrenia (Wium-Andersen, Ørsted, & Nordestgaard, 
2014b). In conventional analyses, elevated plasma levels of C-reactive protein were 
associated with late-onset schizophrenia. The corresponding effect size was similar in MR 
analyses but it was not significant. Because the effect sizes were similar in the two methods, 
the authors concluded that a causal relationship between C-reactive protein and schizophrenia 
could not be excluded. 
Smoking. In addition to depression-related outcomes, Wium-Andersen et al. (2015) 
also investigated the effects of smoking on two separate schizophrenia-related outcomes 
based on Danish national registries: schizophrenia (i.e. ever being diagnosed with 
schizophrenia) and antipsychotic medication use (i.e. ever being prescribed antipsychotic 
medication). The genetic instrument for smoking was significantly associated with 
antipsychotic medication use in ever smoker but not in never-smokers, suggesting a causal 
effect of smoking on antipsychotic medication use (i.e. increased smoking leading to 
increased medication use). The direction of effect was similar for diagnosed schizophrenia but
failed to reach significance. The authors then used summary data from the Psychiatric 
Genomics Consortium to verify whether the genetic instrument for smoking was significantly 
predictive of diagnosed schizophrenia, which was indeed the case. However, they were not 
able to distinguish between smokers and non-smokers in this analysis, which would have 
provided additional evidence that the effect of the genetic instrument was indeed mediated by 
smoking. These results tentatively indicate that higher smoking levels might causally lead to a
higher risk of schizophrenia, contrary to findings on smoking and depression. 
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Homocysteine. Homocysteine is an amino acid found in blood plasma that, in excess, 
is associated with cardiovascular diseases and mental retardation. Two meta-analyses 
conducted by the same research group investigated the potential causal role of homocysteine 
in schizophrenia. The second meta-analysis (Numata et al., 2015) is an extension of the first 
one (Nishi et al., 2014) and included the same and additional studies producing a total of 36 
case-control studies. The genetic instrument, Methylenetetrahydrofolate reductase (MTHFR), 
significantly lowered plasma levels of homocysteine. It was also significantly associated with 
schizophrenia risk, suggesting that higher levels of homocysteine are causally related to a 
higher risk of schizophrenia.
Study of substance use and antisocial behaviour.
 A small study of 180 Asian adolescent adoptees tested the gateway hypothesis, i.e. that 
drinking behaviour in adolescence causes the misuse of other psychoactive substances, and 
antisocial personality disorder (Irons, McGue, Iacono, & Oetting, 2007). The aldehyde 
dehydrogenase 2 (ALDH2) gene was used as a genetic instrument in MR analysis: the 
deficient form of the corresponding enzyme, which is frequent in Asian populations, leads to 
decreased amount of ingested alcohol (because of unpleasant effects of drinking alcohol 
among people with this variant, such as facial flushing and nausea). Adolescent drinking 
behaviours varied significantly in the expected direction as a function of the genetic 
instrument. However, the genetic instrument was not significantly associated with any of the 
substance use and antisocial outcomes. Therefore, these findings do not support the 
hypothesis that alcohol use in adolescence causes the misuse of other psychoactive 
substances, and antisocial personality disorder.
Offspring smoking initiation.
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 The relationship between maternal smoking during and after pregnancy and offspring 
smoking initiation during adolescence (14-16 years) was investigated in a longitudinal study 
(Taylor, Howe, et al., 2014). A maternal SNP in the nicotine acetylcholine receptor gene 
cluster (CHRNA5-A3-B4) was used. Mendelian randomisation analyses did not show 
evidence that the relationship between maternal smoking was causally related to offspring 
smoking initiation and progression to regular smoking. 
 Discussion
In this systematic review, we examined studies using the MR design to assess whether a 
range of potentially modifiable environmental exposures were causally related to 
psychopathology-related outcomes. Conventional analyses adjusting for covariates showed 
significant associations between exposures and psychopathology-related outcomes in the 
expected directions in nearly all studies. However, in most cases, these relations were not 
supported in MR analyses, suggesting that the observed associations were not causal. Based 
on MR analyses, there was some evidence for a causal effect of BMI on depression, anxiety 
and psychological distress but the direction of the findings was not consistent. We first discuss
possible reasons for these null and contradictory findings. Encouragingly, recent MR studies 
suggested a possible causal effect of two exposures – smoking and homocysteine levels – on 
schizophrenia. We discuss these results together with future directions in MR analyses of 
psychopathology.
Reasons for null and contradictory findings
“Most research findings are false” (Ioannidis, 2005)
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Most evidence for relationships between exposures and psychopathology-related outcomes
comes from exploratory epidemiological studies. However, in such observational studies, 
even those that are well-powered and well conducted, most of the reported significant 
findings are likely to be false. This stems in part from the large number of associations tested 
and the threshold commonly used for significance testing (alpha = 0.05). Therefore, it may not
be surprising that studies trying to replicate these associations will fail in most cases. 
Furthermore, even consistent research findings may simply reflect accurate measures of bias 
in a given field (Ioannidis, 2005). This is particularly important here because the aim of MR is
precisely to remove bias due to confounding (i.e. conventional analyses cannot adjust 
adequately for confounding and therefore provide biased estimates of the true causal 
relationship). The fact that most included studies found a significant relationship between 
exposures and psychopathology in conventional analyses is not very conclusive because: (i) 
conventional regression techniques do not always reliably remove bias (Stuart, 2010); (ii) 
included studies controlled only for a limited number of observed confounding variables. A 
good example can be found in the study of C-reactive protein and depression, psychological 
distress and major somatic diseases (Wium-Andersen, Ørsted, & Nordestgaard, 2014a): C-
reactive protein was significantly related to most outcomes in conventional analyses but 
unrelated to any outcome in MR analyses. As pointed by the authors, the estimates from 
conventional and MR analyses were significantly different in several instances. This means 
that MR estimates were not only non-significant but also significantly smaller than estimates 
derived from conventional analysis, suggesting that conventional estimates were inflated by 
confounding. Therefore, because confounding is so widespread, a large proportion of 
significant associations identified using conventional analyses are not likely to be causal, as 
reflected in non-significant findings based on MR analyses. 
              Running head: MENDELIAN RANDOMISATION and PSYCHOPATHOLOGY
23
Alternative causal explanations: reverse causation, timing and sub-populations
Although the majority of included MR studies suggested that exposures did not have 
causal effects on the psychopathology-related outcomes, this does not exclude other possible 
causal relationships between study variables. Reverse causation is a first possibility. For 
instance, increased smoking did not seem to cause depression, anxiety or psychological 
distress. However, it is still possible that depression causes increased smoking (Lewis et al., 
2011). Similarly, high levels of C-reactive protein (signalling inflammation) might be a 
consequence rather than a cause of a number of diseases (Brion et al., 2014). Second, effects 
may change in direction over time. For instance, increased BMI may be related to less 
psychological distress in the short-term given comforting effects of eating, but may lead to 
more psychological distress on the long-term as adverse physical and social consequences 
accumulate. Finally, causal associations may be stronger in sub-groups of the population (e.g. 
obesity and depression in adolescents, see Jokela et al., 2012), or exist only under challenging
circumstances (e.g. fatty acids and depression during pregnancy, see Sallis et al., 2014) 
Heterogeneity in sample size, measures and genetic instruments
Included studies were heterogeneous at several levels, in particular regarding sample size, 
quality of measures and genetic instruments. Sample size varied from a single study of 180 
participants (Irons et al., 2007) to a consortium analysis of over 127,000 participants (Taylor, 
Fluharty, et al., 2014). As such, lack of statistical power may explain some of the null 
findings. Although research regarding power in MR is emerging, some studies were clearly 
underpowered. For example, with a genetic instrument explaining 1% of the variance in the 
exposure, an observed correlation of 0.40 and a true causal correlation between the exposure 
and the outcome of 0.20, almost 20,000 participants are needed to achieve 80% power. Half 
of the reviewed studies included less than 5,000 participants. However, the larger studies had 
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power to detect even small causal effects. For example, the null findings regarding smoking 
and depression in very large samples make it unlikely that there is any substantial causal 
effect (see Brion et al., 2013 for power calculation). In addition, confidence intervals are 
typically larger in MR analyses compared to conventional analyses, which makes it harder to 
detect significant effects.  For instance, the effect sizes of the association between C-reactive 
protein and schizophrenia were similar in conventional and MR analysis, but not significant 
using MR despite the very large sample size (Wium-Andersen, Ørsted, & Nordestgaard, 
2014b). 
There was very considerable heterogeneity in how psychopathology-related outcomes were
measured, from single items assessing psychological distress to clinical diagnoses of 
depression. This adds to the notorious difficulty in the phenotypic characterization in 
psychopathology, as, for instance, patients with very little overlapping symptoms may be 
given the same diagnosis (Sallis et al., 2014; Wium-Andersen, Ørsted, & Nordestgaard, 
2014a). Such heterogeneity does not facilitate the discovery of reliable environmental 
exposures causally associated with psychopathology. Some heterogeneity was also observed 
in the genetic variants that were used. The SNP rs1051730 in the nicotine acetylcholine 
receptor gene cluster (CHRNA5-A3-B4), a gene cluster with a well-documented biological 
function was used in studies of smoking and depression. Conversely, two different SNPs with 
unclear biological function and/or polygenic risk scores with more than 30 SNPs were used to
assess the consequences of increased BMI (although a recent study shed a light on the 
function of rs1421085, a SNP in the FTO region used in Kivimäki, Jokela, Hamer, et al., 
2011, which seems to have pronounced effects on obesity through adipocyte thermogenesis 
regulation, see Claussnitzer et al., 2015).
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 Overall, the use of single variants versus polygenic scores or variants with known versus 
unclear biological functions affect the power to detect an association as well as whether the 
assumptions of MR are plausible. 
Assumption violations
The possibility must also be considered that results from conventional and MR analyses 
differed because assumptions of MR analyses were not fulfilled in some studies. As detailed 
in the introduction, a number of assumptions must be met for MR to yield unbiased estimates 
of a causal effect. Included studies often presented the associations between the genetic 
instruments and potential confounders, which, apart from rare exceptions, were all non-
significant. This shows that genetic instruments seemed largely free from bias due to 
confounding, whilst still strongly predicting the exposure of interest. Therefore, MR analysis 
did seem to have successfully removed bias due to confounding. However, another 
assumption is that the effect of the genetic variant on the outcome is entirely mediated by its 
effect on the exposure. This assumption was not always met. In particular, some associations 
between the genetic instruments used for BMI and outcomes remained largely unchanged 
when controlling for BMI (Lawlor et al., 2011). This means that these genetic variants might 
affect the outcome by pathways other than BMI, violating this assumption and biasing causal 
inference. Such violations of the assumptions may explain some of the aforementioned 
contradictory findings regarding the effects of BMI.  
Future directions: Increasing the scope of MR studies
At this stage, it is important to note that MR analyses have uncovered many likely causal 
associations outside the field of psychopathology, for instance between alcohol intake and 
oesophageal cancer, and tobacco smoking and BMI (Brion et al., 2014). Therefore, the 
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numerous null findings in the present review may simply stem from the fact that, in most 
cases, there were simply no true causal relations between the exposures examined and the 
psychopathology-related outcomes under scrutiny. However, three recent reports suggested a 
potential causal effect of two exposures – i.e. homocysteine and smoking – on schizophrenia. 
Although replication is warranted, these findings are encouraging with regard to the potential 
of MR studies to further our understanding of psychopathology. The application of MR to 
psychopathology is recent. In the next decade, the scope of applications of MR in the field 
should increase rapidly with new research questions being asked and new technical and 
methodological innovations being implemented. 
The vast majority of studies included in this review examined outcomes related to 
depression, anxiety and psychological distress. There seems to be no valid reason why the 
scope of psychopathology-related outcomes examined in MR studies should remained so 
restrictive. For instance, replications of the study on substance use and antisocial behaviour 
(Irons et al., 2007) in larger samples are warranted. Other relevant questions would also 
benefit from an MR approach, such as further elucidating the nature of the relationship 
between smoking and Attention Deficit and Hyperactivity Disorder (McClernon & Kollins, 
2008; Pingault et al., 2013).
Genome-wide information is increasingly available on large datasets, which will 
increase the scope of MR in two ways. First, with more data available, it will become easier to
have adequate sample size to examine new research questions (see Taylor, Fluharty, et al., 
2014 for an example of consortium analysis). MR analysis can often be implemented using 
only summary data from genome-wide association studies (GWAS), which enables the 
hypothesis-free examination of relationships between a large number of genetic instruments 
and outcomes (Evans & Davey Smith, 2015). Second, GWAS are identifying an increasing 
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number of genetic variants associated with psychopathology risk factors and disorders. With 
these additional instruments, it will be possible to address new questions using MR. For 
example, discovering a genetic instrument for cannabis use would provide new insights in the 
long-standing dispute over the putative causal role of cannabis in the onset of schizophrenia. 
A promising avenue to generate new genetic instruments is the use of polygenic risk 
scores or the simultaneous use of multiple SNPs (Burgess & Thompson, 2013; Davies et al., 
2015). Using multiple SNPs has several advantages. First, combining SNPs increases the 
variance explained by the instrument, which is a critical parameter if we are to achieve 
sufficient power in MR analysis. Second, the use of multiple SNPs opens new research 
avenues in case no single SNP instrument is available, which will be particularly useful in the 
case of psychopathology. Indeed, GWAS on psychopathology phenotypes have clearly shown 
that finding any common genetic variant with a large effect is unlikely. Instead, many SNPs 
with small effects have been found for some disorders (Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, 2014) or are yet to be found for others (Major Depressive 
Disorder Working Group of the Psychiatric GWAS Consortium et al., 2013). 
Particularly promising is the possibility of using multiple SNPs in a two-way MR design to 
test reciprocal causal influences. For instance, the studies included in this review indicated 
that heavier smoking does not seem to cause increased depression. However, reverse 
causation is possible as depression may lead to increased smoking. If GWAS successfully 
identify multiple genetic variants that are associated with depression and fulfil the criteria for 
genetic instruments, it then becomes possible to examine this reverse causation hypothesis. 
Similarly, one study included in this  review (Wium-Andersen, Ørsted, & Nordestgaard, 2015)
suggested a causal pathway from smoking to schizophrenia. More than a hundred of genome-
wide significant SNPs associated with schizophrenia have been uncovered in the latest GWAS
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(Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014) and can be 
used to investigate the reciprocal potential causal pathway from schizophrenia to smoking.
Although promising, the use of multiple SNPs has its own drawbacks. A major one is 
horizontal pleiotropy, which happens when a genetic variant has a direct effect on both the 
exposure and the outcome. Horizontal pleiotropy violates the second MR assumption (i.e. that
all the effect of the genetic instrument on the outcome must be mediated by the exposure). 
When using multiple SNPs, the likelihood is high that horizontal pleiotropy will be present 
for some of these SNPs. This is a real concern as pleiotropy is widely spread throughout the 
phenome, including for psychopathology-related outcomes (Evans et al., 2013; Krapohl et al.,
In Press).  Accounting for this potential bias induced by the use of multiple SNPs is an active 
area of research. In particular, a recent method derived from meta-analytic techniques, the 
Egger regression, can be used to estimate pleiotropic effects and generate a causal estimate 
corrected for pleiotropy (Bowden, Davey Smith, & Burgess, 2015).
The number of exposures relevant to psychopathology, which are possible to examine 
using MR, will likely substantially increase due to the discoveries of new single SNP 
instruments and advanced methods for using multiple SNPs. MR studies using few genetic 
variants related to intermediate phenotypes through clear biological pathways (e.g. C-reactive 
protein or uric acid) offer the highest degree of causal evidence (Burgess, Timpson, Ebrahim, 
& Davey Smith, 2015). These studies can be used to validate or invalidate potential targets for
drug development. For instance, drugs targeting C-reactive protein were not further developed
by pharmaceutical companies after MR studies showed no evidence of its causal role in 
cardiovascular diseases (Burgess et al., 2015). This example demonstrates the utility of null 
MR findings in reducing the number of potential intervention targets, and therefore the costs 
of drug development. The same should soon be possible with psychopathology-related 
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outcomes. For instance, studies included in this review point towards homocysteine as a 
relevant target for drug development in schizophrenia. In the case of complex intermediate 
phenotypes influenced by many genetic variants of small effects (e.g. BMI and depression), 
additional caution in the interpretation is warranted given the increased likelihood of 
horizontal pleiotropy and biological pathways that are not well understood. In this case, MR 
studies can be used to probe the plausibility of a causal relationship and investigate potential 
causal pathways (Burgess et al., 2015).
Finally, it is worth noting that adequate genetic instruments may never be found for a 
number of important risk factors for psychopathology, for instance neighbourhood or 
parenting characteristics, in which case alternative methods to strengthen causal inference 
(e.g. discordant monozygotic twin design) may be used.  
 ------------------------------------------------------------------------
Box 2: MR in the “omics era”: understanding developmental mechanisms
The scope of MR will also increase with the availability of “omics” data such as proteomic
data or epigenetic data (Brion et al., 2014). Here, we focus on epigenetics as a potential 
‘missing link’ in the aetiology of complex disorders. Epigenetic mechanisms, such as DNA 
methylation, influence dynamic changes in transcription independently of genomic sequence 
(Jaenisch & Bird, 2003). Altered DNA methylation patterns have been shown to associate 
with both environmental risk exposure such as prenatal diet or childhood maltreatment (Lutz 
& Turecki, 2014; Tobi et al., 2014) as well as a range of psychopathology-related outcomes, 
for instance major depression, posttraumatic stress and schizophrenia (Fuchikami et al., 2011; 
Klengel, Pape, Binder, & Mehta, 2014; Wockner et al., 2014). Together, these findings have 
provided initial support for the role of epigenetic processes as a mediator in the link between 
environmental influences and psychopathology-related outcomes. However, establishing the 
causality of epigenetic associations has been challenging, not least because epigenetic 
markers are equally as susceptible to confounding, measurement error and reverse causation 
as the environmental exposures themselves (Relton & Davey Smith, 2012a). For example, it 
is presently unclear whether altered DNA methylation patterns are truly a risk factor for – or a
consequence of – psychopathology-related outcomes. Consequently, epigenetic epidemiology 
needs to integrate causal inference methods.
In response to this need, a two-step epigenetic extension to MR has recently been proposed
to test causal mediation (Relton & Davey Smith, 2012b). While the method was originally 
developed with epigenetics in mind, it may be applied to other mediating variables as well 
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(Brion et al., 2014). In two-step MR, the first step assesses the causal association between the 
independent variable (e.g. modifiable environmental exposure) and the mediator (e.g. DNA 
methylation), while the second step assesses the causal association between the mediator and 
the dependent variable (e.g. psychopathology-related outcome). Each step can also be 
performed in isolation. In Step 1, a genetic variant is used as a proxy for an environmental 
exposure. As with standard MR, causality is supported only if the genetic proxy is associated 
with the epigenetic marker exclusively through its association with the environmental 
exposure. With regards to the mediator, several strategies have been proposed for identifying 
appropriate DNA methylation markers, including the application of epigenome-wide and 
candidate gene strategies (Relton & Davey Smith, 2012a). In Step 2, a genetic proxy for DNA
methylation – specifically, a local genotype (cis- SNP) – is used to obtain an unbiased 
estimate for the effect of DNA methylation on the psychopathology-related outcome. In 
conjunction, these steps can clarify whether epigenetic processes mediate environmental 
effects on a psychopathology-related outcome. 
Although two-step MR shows promise as a method for testing causal mediation, it is 
still in its infancy and currently lacks empirical investigation, particularly with regards to 
psychiatric phenotypes (Kirkbride et al., 2012). Furthermore, epigenetic MR faces a number 
of additional challenges on top of those previously described in relation to standard MR (e.g. 
population stratification, LD and pleiotropy).  First, epigenetic associations are usually only 
modest in size (Brion et al., 2014). Second, because of low statistical power, the MR design 
requires a much larger sample size than what is typically available for epigenetic studies. This
is particularly true for studies that examine methylation in central, as opposed to peripheral 
(e.g. blood, saliva) tissues. Third, in contrast to genomic sequence which remains fixed, 
epigenetic markers have been shown to vary both across tissues and across time (Mill & 
Heijmans, 2013). Such sources of variability may greatly influence the associations under 
investigations, as epigenetic effects may be limited to specific tissues or developmental 
periods. Despite the above challenges, the application of two-step MR may offer novel 
insights into causal developmental pathways, as well as elucidating whether environmental 
exposures ‘get under the skin’ to influence psychopathology-related outcomes via epigenetic 
processes.
------------------------------------------------------------------------ 
Limitations
The main limitation of the present systematic review is that we did not conduct meta-
analyses. Meta-analyses are particularly interesting in MR as they increase the power to detect
any causal association. Several reports included in this review used meta-analyses (Numata et 
al., 2015; Taylor, Fluharty, et al., 2014). However, meta-analyses seem premature for most 
pairs of exposure-outcome variables at this stage as few studies were available and, for each 
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of these pairs, the heterogeneity in outcome definition and genetic instruments was 
considerable.
Conclusions
We systematically reviewed studies that applied the MR design to psychopathology-related
outcomes. In conventional analyses, associations between exposures and outcomes were 
generally significant and in the expected directions. However, MR analyses often contradicted
these results by providing very little consistent evidence that any of these associations were 
causal. These findings highlight the potentially strong bias in conventional analyses of risk 
factors in psychopathology. The implications are far reaching in that even replicated findings 
based on conventional designs and analyses may not be reliable enough to meaningfully 
inform drug development as well as preventive interventions and policies. Most recent studies
and methodological innovations highlight the potential of well-designed and well-powered 
MR studies to contribute to a better identification of relevant causal risk factors in 
psychopathology.
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Table 1: Characteristics of the studies included in the systematic review
Reference Sample N Exposure Outcome Genetic instrument Findings
(Lewis et al., 
2011)
ALSPAC, UK 6294 Smoking Antenatal depression Nicotine acetylcholine 
receptor gene cluster 
(CHRNA5-A3-B4), 1 SNP
Smoking does not cause 
increased depression. 
Conversely, findings are 
consistent with a self-
medication hypothesis, 
whereby depressed women 
smoke to alleviate their 
symptoms.
(Bjørngaard et
al., 2013)
Norwegian HUNT 
study
53601 Smoking Anxiety and 
Depression 
Nicotine acetylcholine 
receptor gene cluster 
(CHRNA5-A3-B4), 1 SNP
Smoking is not a cause of 
anxiety or depression
(Taylor, 
Fluharty, et 
al., 2014)
Carta Consortium 127632 Smoking Depression, anxiety 
and psychological 
distress
Nicotine acetylcholine 
receptor gene cluster 
(CHRNA5-A3-B4), 2 SNPs
No evidence for a causal role of
smoking heaviness in the 
development of depression or 
anxiety
(Wium-
Andersen, 
Ørsted, & 
Nordestgaard, 
2015)
Copenhagen 
General 
Population Study 
and Copenhagen 
City Heart Study
63296 Smoking Depression & 
Schizophrenia and 
respective 
medications
Nicotine acetylcholine 
receptor gene cluster 
(CHRNA5-CHRNA3-
CHRNB4), 1 SNP
Smoking does not cause 
Depression but some evidence 
that it does for Schizophrenia
(Almeida et 
al., 2014)
Health In Men 
Study, Australia
3873 Alcohol Depression Alcohol dehydrogenase 1B 
(ADH1B), 1 SNP
Alcohol does not cause 
depression
(Wium-
Andersen, 
Ørsted, 
Tolstrup, et 
al., 2015)
Copenhagen 
General 
Population Study 
and Copenhagen 
City Heart Study
78154 Alcohol Depression, 
psychological 
distress, and 
alcoholism
Alcohol dehydrogenase 1B 
(ADH1B) and ADH1C, 2 
SNPs
Alcohol does not cause 
depression but is causally 
linked with 
hospitalization/death with 
alcoholism
(Hung et al., RADIANT 3222 BMI Major depression Fat mass and obesity- No evidence for a causal 
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2014) associated (FTO) gene, 1 
SNP, and genetic risk score 
based on 32 SNPs
relationship between BMI and 
major depression
(Kivimäki, 
Jokela, 
Hamer, et al., 
2011)
Whitehall II study 4145 BMI Common mental 
disorder (anxiety and
depression)
Fat mass and obesity-
associated (FTO) gene, 1 
SNP 
MR analysis shows that BMI 
increases the risk of common 
mental disorder in men only
(Jokela et al., 
2012)
Young Finns 1731 BMI Depression Genetic risk score, 31 SNPs MR analysis supports a causal 
association between excessive 
BMI and increased risk of 
depressive symptoms
(Lawlor et al., 
2011)
Copenhagen 
General 
Population Study 
and Copenhagen 
City Heart Study
53221 BMI  Psychological 
distress 
Fat mass and obesity-
associated (FTO) gene, 1 
SNP and Melanocortin 
receptor 4 (MC4R), 1 SNP 
MR analysis shows that higher 
BMI and WHR is associated 
with less psychological distress.
(Walter et al., 
2015)
Female Nurse’s 
Health Study
6989 BMI Depression Fat mass and obesity-
associated (FTO) gene, 1 
SNP and melanocortin 
receptor 4 (MC4R), 1 SNP, 
as well as a polygenic risk 
score based on 32 SNPs
No evidence for a causal role of
BMI on depression
(Sallis et al., 
2014)
ALSPAC, UK 3397 Docosahex
aenoicacid
(DHA) 
and 
eicosapent
aenoicacid
(EPA)
Perinatal, antenatal 
and postnatal 
depression  
Polygenic risk scores, EPA, 
23 SNPs and DHA, 4 SNPs
No evidence that fatty acids are
causally related to depression 
outcomes
(Almeida et 
al., 2009)
Health In Men 
Study, Australia
3700 C-reactive 
protein 
Depression CRP gene, 2 SNPs Depressive symptoms in later 
life are unlikely caused by an 
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(CRP) increase in the plasma level of 
CRP
(Wium-
Andersen, 
Ørsted, & 
Nordestgaard, 
2014a)
Copenhagen 
General 
Population Study 
and Copenhagen 
City HearStudy
78,809 C-reactive 
protein 
(CRP)
Depression, 
psychological 
distress and major 
somatic diseases
CRP gene, 4 SNPs No evidence that increased C-
reactive protein levels cause 
depression
(Wium-
Andersen, 
Ørsted, & 
Nordestgaard, 
2014b)
Copenhagen 
General 
Population Study 
and Copenhagen 
City HearStudy
78810 C-reactive 
protein 
(CRP)
Schizophrenia CRP gene, 4 SNPs No significant evidence that 
elevated C-reactive protein is 
causally related to 
schizophrenia, although a 
causal relationship cannot be 
excluded
(Nishi et al., 
2014) 
Meta-analysis of 6 
Japanese studies
10,378 homocyste
ine
Schizophrenia Methylenetetrahydrofolate 
reductase (MTHFR), 1 SNP
Evidence of causal relationship 
between higher homocysteine 
levels and higher risk of 
schizophrenia
(Numata et 
al., 2015)
Meta-analysis of 
36 case control 
studies
25,599 homocyste
ine
Schizophrenia Methylenetetrahydrofolate 
reductase (MTHFR), 1 SNP
Evidence of causal relationship 
from higher homocysteine 
levels to higher risk of 
schizophrenia
(Irons et al., 
2007)
Sibling Interaction 
and  behaviour 
Study
180 Alcohol  Nicotine 
dependence, drug 
abuse and 
dependence, 
antisocial personality
disorder
Aldehyde dehydrogenase 2 
(ALDH2), 1 SNP
Evidence of causal relationship 
from higher homocysteine 
levels to higher risk of 
schizophrenia
(Taylor, 
Howe, et al., 
2014)
ALSPAC, UK 1020 Maternal 
smoking
Offspring smoking 
initiation  
Nicotine acetylcholine 
receptor gene cluster 
(CHRNA5-A3-B4), 1 SNP
No evidence that maternal 
smoking is causally related to 
offspring smoking initiation in 
adolescence
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Figure 1: Representation of Mendelian randomisation 
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Figure Legend: Mendelian randomisation uses a genetic instrument associated with an exposure in order to test whether the association 
between the exposure A and an outcome B (path 3) is causal. An adequate genetic instrument must be robustly associated with the exposure 
(solid path 1), but not be associated with the confounders (dashed path 4). The latter condition is key so that MR estimation is not affected by 
variables that confound the association between the exposure and the outcome in conventional observational research (5 & 6). Following the 
principles of instrumental variables, a significant association between the genetic instrument and the outcome is interpreted as evidence of the 
causal relationship between the exposure and the outcome. Importantly, all the effect of the genetic instrument on the outcome should happen 
through the exposure. Therefore, no direct effect must remain once the exposure is taken into account. This is why path (2) is dashed in the 
Figure, which includes the exposure. However, it is important to note that the observed value of path (2) is expected to be significant, which is 
how we assess if there is a causal relationship between A and B. This is similar to a full mediation analysis where the direct path between a 
predictor X and an outcome Y (path often labelled c) is not significant when the effect of the mediator M is taken into account (i.e. the new path, 
labelled c’, is not significant). Finally, the causal estimate of path (3) can be estimated based on the observed values of path (1) and (2). 
              Running head: MENDELIAN RANDOMISATION and PSYCHOPATHOLOGY 49
Figure 2. Analogy between Mendelian Randomisation and Randomised Controlled Trials (adapted from Davey Smith & Ebrahim, 2005)
